1.Human KIAA1018/FAN1 nuclease is a new mitotic substrate of APC/C(Cdh1).
Fenju LAI ; Kaishun HU ; Yuanzhong WU ; Jianjun TANG ; Yi SANG ; Jingying CAO ; Tiebang KANG
Chinese Journal of Cancer 2012;31(9):440-448
A recently identified protein, FAN1 (FANCD2-associated nuclease 1, previously known as KIAA1018), is a novel nuclease associated with monoubiquitinated FANCD2 that is required for cellular resistance against DNA interstrand crosslinking (ICL) agents. The mechanisms of FAN1 regulation have not yet been explored. Here, we provide evidence that FAN1 is degraded during mitotic exit, suggesting that FAN1 may be a mitotic substrate of the anaphase-promoting cyclosome complex (APC/C). Indeed, Cdh1, but not Cdc20, was capable of regulating the protein level of FAN1 through the KEN box and the D-box. Moreover, the up- and down-regulation of FAN1 affected the progression to mitotic exit. Collectively, these data suggest that FAN1 may be a new mitotic substrate of APC/CCdh1 that plays a key role during mitotic exit.
Anaphase-Promoting Complex-Cyclosome
;
Bone Neoplasms
;
metabolism
;
pathology
;
Cadherins
;
genetics
;
metabolism
;
Cdc20 Proteins
;
Cell Cycle Proteins
;
genetics
;
metabolism
;
Cell Line, Tumor
;
Exodeoxyribonucleases
;
genetics
;
metabolism
;
HEK293 Cells
;
Humans
;
Mitosis
;
Osteosarcoma
;
metabolism
;
pathology
;
Ubiquitin-Protein Ligase Complexes
;
genetics
;
metabolism
2.What is the Meaning of Anaphase-Promoting Complex 7 in Malignant Neoplasms?.
Annals of Coloproctology 2017;33(4):123-124
No abstract available.
Anaphase-Promoting Complex-Cyclosome
;
Neoplasms
;
Cell Nucleus
;
Colorectal Neoplasms
;
Anaplasia
;
Aneuploidy
3.Expression of Anaphase Promoting Complex (APC) and APC Regulatory Proteins in Invasive Ductal Carcinoma Associated with Paget's Disease.
Kwang Hwa PARK ; Sang Yeop YI ; Woo Ick YANG ; Yup KANG ; Kwang Gil LEE
Korean Journal of Pathology 2004;38(5):319-323
BACKGROUND: Oncogene expression in Paget's disease of the breast is not well known. To characterize invasive ductal carcinoma associated with Paget's disease, we studied expression of anaphase promoting complex (APC) with its regulatory proteins. METHODS: Immunohistochemical stainings were done with 10 cases of invasive ductal carcinoma associated with Paget's disease for APC, pituitary tumor transforming gene (PTTG), cyclin B1, p53, cyclin D1, and c-erbB-2. The expressions of these markers in Paget's disease were compared with those in the associated with carcinoma. RESULTS: APC, PTTG, cyclin B1, and c-erbB-2 were positive in all of the cases with both Paget's disease and underlying carcinoma. p53 was expressed in Paget's disease of 6 cases (60%) and in carcinoma of 7 cases (70%). Cyclin D1 was positive in Paget's disease of 8 cases (80%) and in carcinoma of 9 cases (90%). CONCLUSIONS: Breast carcinomas with Paget's disease seem to be distinguished by the high expression of APC, cyclin B1, PTTG, c-erbB2, and cyclin D1 in contrast to breast cancers without Paget's disease. Furthermore, the similar expression patterns of APC and APC regulatory proteins in both Paget's disease and underlying breast cancer support the epidermotropic theory as its pathogenetic mechanism.
Anaphase*
;
Anaphase-Promoting Complex-Cyclosome*
;
Breast
;
Breast Neoplasms
;
Carcinoma, Ductal*
;
Cyclin B1
;
Cyclin D1
;
Oncogenes
;
Paget's Disease, Mammary
;
Pituitary Neoplasms
4.Anaphase-Promoting Complex 7 is a Prognostic Factor in Human Colorectal Cancer.
Ik Yong KIM ; Hye Yeon KWON ; Kwang Hwa PARK ; Dae Sung KIM
Annals of Coloproctology 2017;33(4):139-145
PURPOSE: The anaphase-promoting complex (APC) is a multiprotein complex with E3 ubiquitin ligase activity and is required for ubiquitination of securin and cyclin-B. Several APC-targeting molecules are reported to be oncogenes. Dysregulation of APC may be associated with tumorigenesis. This study examines the relationship between APC expression and clinicopathological factors and evaluates the possibility of an aberrant APC function in colorectal carcinomas (CRCs). METHODS: To determine whether the loss of APC7 expression is related to tumorigenesis, we used tissue micro-arrays in 114 resected CRCs to scrutinize the expressions of APC7 and Ki-67 immunohistochemistry and to find relations with clinocopathologic parameters. The expression of APC7 was defined as positive for summed scores of staining intensities from 0 to 3+. RESULTS: Forty-four cases (67.7%) of colon cancer and 38 cases (77.6%) of rectal cancer showed immunopositive reactions to APC. The grade of APC expression was not statistically correlated with tumor location, age, T or TNM stage, or differentiation. However, the expression of APC did correlate with the expression of Ki-67 and to the tumor recurrent. Higher APC expression showed the better 5-year overall survival rate in 74% of grades 2, 3 groups (high expression) than 57% of grades 0, 1 groups (lower expression) respectively (P = 0.042). CONCLUSION: Positive APC expression may be a good prognostic factor for patients with CRC, and the loss of APC expression in tumor tissue may be related with the risk for recurrence and a poor survival rate compared to high APC expression. Further study of APC in controlling the cell cycle as aberrant function in CRC is needed.
Adenocarcinoma
;
Anaphase-Promoting Complex-Cyclosome
;
Carcinogenesis
;
Cell Cycle
;
Colonic Neoplasms
;
Colorectal Neoplasms*
;
Humans*
;
Immunohistochemistry
;
Oncogenes
;
Rectal Neoplasms
;
Recurrence
;
Securin
;
Survival Rate
;
Ubiquitin
;
Ubiquitin-Protein Ligases
;
Ubiquitination
5.Expression of Anaphase Promoting Complex in Surgically Resected Squamous Cell Carcinoma and Adenocarcinoma of the Lung.
Ji Sun SONG ; Soon Hee JUNG ; Minseob EOM ; Sang Yeop YI ; Kwang Hwa PARK ; Yup KANG ; Ho Young KIM
Korean Journal of Pathology 2006;40(1):52-59
BACKGROUND: The anaphase promoting complex (APC) promotes the degradation of mitotic cyclins as well as other substrates involved in sister chromatid adhesion. This study was carried out to examine the relationship between the APC expression and the clinicopathological variables, in an attempt to determine the role of the APC in the proliferation of lung cancer and to evaluate the possibility of an aberrant APC function in surgically resected squamous cell carcinomas and adenocarcinomas of the lung. METHODS: Immunohistochemical staining was performed for APC, Ki-67, cyclin B1, Cdc2, MMP-2 and VEGF in 55 cases of squamous cell carcinoma and 34 cases of adenocarcinoma of the lung, using the avidin-biotin-peroxidase method. RESULTS: The immunohistochemical stains for APC revealed a positive reaction in 49 cases (55.1%). The APC expression level was higher in the cyclin B1-positive group (p= 0.01), the Cdc2-positive group (p=0.001), the MMP-2-positive group (p=0.03), the group with lymph node metastasis (61.4% vs 48.9%), and the group with stage II/III cancer (60.7%) compared with those with stage I (42.9%). CONCLUSIONS: The APC may have an aberrant function, such as a change in its role in controlling the cell cycle, and might be associated with the invasiveness and proliferation of tumor cells.
Adenocarcinoma*
;
Anaphase*
;
Anaphase-Promoting Complex-Cyclosome*
;
Carcinoma, Squamous Cell*
;
Cell Cycle
;
Chromatids
;
Coloring Agents
;
Cyclin B1
;
Cyclins
;
Humans
;
Lung Neoplasms
;
Lung*
;
Lymph Nodes
;
Neoplasm Metastasis
;
Siblings
;
Vascular Endothelial Growth Factor A
6.CUEDC2: an emerging key player in inflammation and tumorigenesis.
Protein & Cell 2011;2(9):699-703
CUE domain-containing 2 (CUEDC2) is a protein involved in the regulation of the cell cycle, inflammation, and tumorigenesis and is highly expressed in many types of tumors. CUEDC2 is phosphorylated by Cdk1 during mitosis and promotes the release of anaphase-promoting complex or cyclosome (APC/C) from checkpoint inhibition. CUEDC2 is also known to interact with IkB kinase α (IKKα) and IKKβ and has an inhibitory role in the activation of transcription factor nuclear factor-κB. Moreover, CUEDC2 plays an important role in downregulating the expression of hormone receptors estrogen receptor-α and progesterone receptor, thereby impairing the responsiveness of breast cancer to endocrine therapies. In this review, current knowledge on the multi-functions of CUEDC2 in normal processes and tumorigenesis are discussed and summarized.
Anaphase-Promoting Complex-Cyclosome
;
Breast Neoplasms
;
pathology
;
Carrier Proteins
;
metabolism
;
Cell Cycle Proteins
;
metabolism
;
Cell Transformation, Neoplastic
;
pathology
;
Estrogen Receptor alpha
;
metabolism
;
Female
;
Humans
;
I-kappa B Kinase
;
metabolism
;
Inflammation
;
pathology
;
M Phase Cell Cycle Checkpoints
;
Membrane Proteins
;
metabolism
;
Mitosis
;
NF-kappa B p50 Subunit
;
metabolism
;
Receptor-Interacting Protein Serine-Threonine Kinases
;
metabolism
;
Signal Transduction
;
Ubiquitin-Protein Ligase Complexes
;
metabolism
;
Ubiquitination
7.Effects of Arsenic Trioxide on Cdc20 and Mad2 in Acute Myeloid Leukemia HL-60 Cell Line.
Shu-Min DING ; Rui-Rong XU ; Jin-Yao KAN ; Yan WANG
Journal of Experimental Hematology 2018;26(3):710-715
OBJECTIVETo investigate the effects of arsenic trioxide (AsO) on Cdc20 and Mad2 in process of AML HL-60 cell proliferation.
METHODSThe proliferation of HL-60 cells was detected by CCK-8 method at different concentrations of arsenic trioxide for 24, 48 and 72 hours. The cell morphological changes were observed by inverted microscopy. The expressions of Mad2 and Cdc20 mRNA and protein in HL-60 cells treated with AsO for 48 h were detected by real-time PCR and Western blot respectively.
RESULTSArsenic trioxide significantly inhibited the HL-60 cell proliferation and displayed a good time-dose correlation. RT-PCR and Western blot showed that the expression of Mad2 was up-regulated and the expression of Cdc20 was down-regulated in HL-60 cells treated with arsenic trioxide of different concentration (4,8,10 µmol/L).
CONCLUSIONArsenic trioxide can inhibit the human acute myeloid leukemia HL-60 cell proliferation, and its mechanism may be related with up-regulation of Mad2 expression and down-regulation of Cdc20 expression.
Antineoplastic Agents ; Apoptosis ; Arsenic Trioxide ; Arsenicals ; Cdc20 Proteins ; HL-60 Cells ; Humans ; Leukemia, Myeloid, Acute ; Oxides
8.Biallelic mutations in CDC20 cause female infertility characterized by abnormalities in oocyte maturation and early embryonic development.
Lin ZHAO ; Songguo XUE ; Zhongyuan YAO ; Juanzi SHI ; Biaobang CHEN ; Ling WU ; Lihua SUN ; Yao XU ; Zheng YAN ; Bin LI ; Xiaoyan MAO ; Jing FU ; Zhihua ZHANG ; Jian MU ; Wenjing WANG ; Jing DU ; Shuai LIU ; Jie DONG ; Weijie WANG ; Qiaoli LI ; Lin HE ; Li JIN ; Xiaozhen LIANG ; Yanping KUANG ; Xiaoxi SUN ; Lei WANG ; Qing SANG
Protein & Cell 2020;11(12):921-927
9.CCT4 suppression inhibits tumor growth in hepatocellular carcinoma by interacting with Cdc20.
Feng LI ; Chun-Sheng LIU ; Ping WU ; An-Sheng LING ; Qi PAN ; Xiao-Ning LI
Chinese Medical Journal 2021;134(22):2721-2729
BACKGROUND:
The chaperonin containing t-complex (CCT) proteins play an important role in cell cycle-related protein degradation in yeast and mammals. The role of the chaperonin containing t-complex 4 (CCT4), one subtype of CCT proteins, in the progress of hepatocellular carcinoma (HCC) was not fully elucidated. Here, we aimed to explore the mechanisms of CCT4 in HCC.
METHODS:
In this study, we used the UALCAN platform to analyze the relationship between CCT4 and HCC, and the association of CCT4 with the overall survival (OS) of HCC patients was also analyzed. CCT4 expression in HCC tumor tissues and normal tissues was also determined by western blot (WB) assay. Lentivirus vector was used to knock down the CCT4 expression, and quantitative polymerase chain reaction and WB were used to determine the level of CCT4 in HCC cell lines. Cell counting kit-8 (CCK-8) and 5-ethynyl-2'-deoxyuridine (EdU) assays were used to detect the cell proliferation, and flow cytometry (FCM) was performed to evaluate the effect of CCT4 on the apoptosis of HCC cells. Co-immunoprecipitation (co-IP) assay and WB were used to explore the mechanisms of CCT4 regulating the growth of HCC. Data were calculated from at least three replicate experiments and expressed as mean ± standard deviation. Student's t test, paired t test, and Kaplan-Meier analysis were used to compare across different groups.
RESULTS:
We found CCT4 was upregulated in HCC tissues compared with normal tissues, and its high expression was associated with poor prognosis (P < 0.001). CCT4 was significantly increased in HCC tumor tissues compared with normal tissues (0.98 ± 0.12 vs. 0.23 ± 0.05, t = 7.73, P < 0.001). After being transfected with CCT4 short-hairpin RNA (shRNA), CCT4 was decreased in mRNA level and protein level in both Huh7 (mRNA level: 0.41 ± 0.07 vs. 1.01 ± 0.11, t = 8.09, P = 0.001; protein level: 0.61 ± 0.03 vs. 0.93 ± 0.07, t = 7.19, P = 0.002) and Hep3b cells (mRNA level: 0.55 ± 0.11 vs. 1.04 ± 0.15, t = 4.51, P = 0.011; protein level: 0.64 ± 0.10 vs. 0.95 ± 0.08, t = 4.32, P = 0.012). CCK8 assay indicated that CCT4 knockdown inhibited cell proliferation in both Huh7 (OD value of 3 days: 0.60 ± 0.14 vs. 0.97 ± 0.16, t = 3.13, P = 0.036; OD value of 4 days: 1.03 ± 0.07 vs. 1.50 ± 0.12, t = 5.97, P = 0.004) and Hep3b (OD value of 3 days: 0.69 ± 0.14 vs. 1.10 ± 0.11, t = 3.91, P = 0.017; OD value of 4 days: 1.12 ± 0.12 vs. 1.48 ± 0.13, t = 3.55, P = 0.024) cells. EdU assay showed that CCT4 knockdown inhibited the cell proliferation in both Huh7 (EdU positive rate: [31.25 ± 3.41]% vs. [58.72 ± 3.78]%, t = 9.34, P = 0.001) and Hep3b cells (EdU positive rate: [44.13 ± 7.02]% vs. [61.79 ± 3.96]%, t = 3.79, P = 0.019). FCM assay suggested that CCT4 knockdown induced apoptosis in HCC cells (apoptosis rate of Huh7: [9.10 ± 0.80]% vs. [3.66 ± 0.64]%, t = -9.18, P = 0.001; apoptosis rate of Hep3b: [6.69 ± 0.72]% vs. [4.20 ± 0.86]%, t = -3.84, P = 0.018). We also found that CCT4 could regulate anaphase-promoting complex (APC)Cdc20 activity via interacting with Cdc20. Furthermore, CCT4 knockdown induced securin (0.65 ± 0.06 vs. 0.44 ± 0.05, t = -4.69, P = 0.009) and B-cell lymphoma-2 (Bcl-2) interacting mediator of cell death (Bim; 0.96 ± 0.06 vs. 0.61 ± 0.09, t = -5.65, P = 0.005) accumulation. The upregulation of securin inhibited cell growth by downregulating cyclin D1 (0.65 ± 0.05 vs. 1.04 ± 0.07, t = 8.12, P = 0.001), and the accumulation of Bim inhibited Bcl-2 (0.77 ± 0.04 vs. 0.87 ± 0.04, t = 3.00, P = 0.040) and activated caspase 9 (caspase 9: 0.77 ± 0.04 vs. 0.84 ± 0.05, t = 1.81, P = 0.145; cleaved caspase 9: 0.64 ± 0.06 vs. 0.16 ± 0.07, t = 1.81, P = 0.001), which led to elevated apoptosis.
CONCLUSIONS
Overall, these results showed that CCT4 played an important role in HCC pathogenesis through, at least partly, interacting with Cdc20.
Animals
;
Apoptosis
;
Carcinoma, Hepatocellular/genetics*
;
Cdc20 Proteins
;
Cell Line, Tumor
;
Cell Proliferation/genetics*
;
Gene Expression Regulation, Neoplastic
;
Humans
;
Liver Neoplasms/genetics*
10.DNA replication components as regulators of epigenetic inheritance--lesson from fission yeast centromere.
Haijin HE ; Marlyn GONZALEZ ; Fan ZHANG ; Fei LI
Protein & Cell 2014;5(6):411-419
Genetic information stored in DNA is accurately copied and transferred to subsequent generations through DNA replication. This process is accomplished through the concerted actions of highly conserved DNA replication components. Epigenetic information stored in the form of histone modifications and DNA methylation, constitutes a second layer of regulatory information important for many cellular processes, such as gene expression regulation, chromatin organization, and genome stability. During DNA replication, epigenetic information must also be faithfully transmitted to subsequent generations. How this monumental task is achieved remains poorly understood. In this review, we will discuss recent advances on the role of DNA replication components in the inheritance of epigenetic marks, with a particular focus on epigenetic regulation in fission yeast. Based on these findings, we propose that specific DNA replication components function as key regulators in the replication of epigenetic information across the genome.
Cdc20 Proteins
;
antagonists & inhibitors
;
genetics
;
metabolism
;
Centromere
;
metabolism
;
Chromatin
;
metabolism
;
Chromosomal Proteins, Non-Histone
;
metabolism
;
DNA Replication
;
DNA, Fungal
;
metabolism
;
Epigenesis, Genetic
;
Histones
;
metabolism
;
Schizosaccharomyces
;
genetics
;
metabolism
;
Schizosaccharomyces pombe Proteins
;
antagonists & inhibitors
;
genetics
;
metabolism